Pretax income is the income that a company earns before paying income taxes. Tengion's pretax income for the
three
months ended in Sep. 2014 was $-18.35 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Sep. 2014 was $-64.43 Mil.
Tengion's pretax margin was %.
Tengion Pre-Tax Income Historical Data
The historical data trend for Tengion's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Tengion's Pre-Tax Income
For the Biotechnology subindustry, Tengion's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tengion's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tengion's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Tengion's Pre-Tax Income falls into.
Tengion Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Tengion's Pretax Income for the fiscal year that ended in Dec. 2013 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-64.43 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tengion (GREY:TNGNQ) Pre-Tax Income Explanation
Tengion's Pretax Margin for the quarter that ended in Sep. 2014 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tengion Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Tengion's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Tengion Inc is a regenerative medicine company. The company is engaged in discovering, manufacturing and commercializing neo-organs, or products composed of living cells, with or without synthetic or natural materials, implanted or injected into the body to engraft into, regenerate, or replace damaged tissue or organ. Its product candidates seek to eliminate the need to utilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications. The company's solution Neo-Kidney Augment is based on its proprietary technology, which uses tubular epithelial cells, procured by a cortical biopsy of the patient's kidney, to create an injectable product candidate that can catalyze the regeneration of functional kidney tissue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TNGNQ has been successfully added to your 